PURPOSE: To demonstrate the feasibility of PC-VIPR (Phase Contrast Vastly undersampled Imaging with Projection Reconstruction) for the depiction and hemodynamic analysis of hepatic and splanchnic vessels in patients with portal hypertension. MATERIALS AND METHODS: Twenty-four cirrhotic patients (55.9 ± 10.4 years) were scanned using 5-point PC-VIPR for high spatial resolution imaging with large volume coverage at 3 Tesla (T) using a 32-channel body coil. Vessel segmentation and hemodynamic visualization included color-coded three-dimensional (3D) streamlines and particle traces. Segmentation quality was compared with contrast-enhanced multi-phase liver imaging. Flow pattern analysis was performed in consensus of three readers. The MELD score was calculated to estimate disease severity and was correlated to image quality. RESULTS: Good to excellent visualization quality was achieved in 23/24 cases. All arterial vessels and 144/168 vessels of the portal venous (PV) circulation were unambiguously identified. No correlation with the MELD score was found. Eight of 148 vessels of the PV circulation demonstrated reverse (hepatofugal) flow. Hepatofugal flow in small tributaries to PV flow were present in three cases despite hepatopetal flow in the PV. CONCLUSION: This feasibility study demonstrates the feasibility of PC-VIPR for simultaneous morphological and hemodynamic assessment of the hepatic and splanchnic vasculature in cirrhosis and portal hypertension. Future studies with quantitative analyses are warranted.
PURPOSE: To demonstrate the feasibility of PC-VIPR (Phase Contrast Vastly undersampled Imaging with Projection Reconstruction) for the depiction and hemodynamic analysis of hepatic and splanchnic vessels in patients with portal hypertension. MATERIALS AND METHODS: Twenty-four cirrhotic patients (55.9 ± 10.4 years) were scanned using 5-point PC-VIPR for high spatial resolution imaging with large volume coverage at 3 Tesla (T) using a 32-channel body coil. Vessel segmentation and hemodynamic visualization included color-coded three-dimensional (3D) streamlines and particle traces. Segmentation quality was compared with contrast-enhanced multi-phase liver imaging. Flow pattern analysis was performed in consensus of three readers. The MELD score was calculated to estimate disease severity and was correlated to image quality. RESULTS: Good to excellent visualization quality was achieved in 23/24 cases. All arterial vessels and 144/168 vessels of the portal venous (PV) circulation were unambiguously identified. No correlation with the MELD score was found. Eight of 148 vessels of the PV circulation demonstrated reverse (hepatofugal) flow. Hepatofugal flow in small tributaries to PV flow were present in three cases despite hepatopetal flow in the PV. CONCLUSION: This feasibility study demonstrates the feasibility of PC-VIPR for simultaneous morphological and hemodynamic assessment of the hepatic and splanchnic vasculature in cirrhosis and portal hypertension. Future studies with quantitative analyses are warranted.
Authors: Tianliang Gu; Frank R Korosec; Walter F Block; Sean B Fain; Quill Turk; Darren Lum; Yong Zhou; Thomas M Grist; Victor Haughton; Charles A Mistretta Journal: AJNR Am J Neuroradiol Date: 2005-04 Impact factor: 3.825
Authors: Jing Liu; Michael J Redmond; Ethan K Brodsky; Andrew L Alexander; Aiming Lu; Francis J Thornton; Michael J Schulte; Thomas M Grist; James G Pipe; Walter F Block Journal: IEEE Trans Med Imaging Date: 2006-02 Impact factor: 10.048
Authors: G R Applegate; F L Thaete; S P Meyers; P L Davis; S L Talagala; M Recht; P Wozney; E Kanal Journal: Radiology Date: 1993-04 Impact factor: 11.105
Authors: Vlad Ratziu; Luminita Bonyhay; Vincent Di Martino; Frederic Charlotte; Lucas Cavallaro; Marie-Hélène Sayegh-Tainturier; Philippe Giral; André Grimaldi; Pierre Opolon; Thierry Poynard Journal: Hepatology Date: 2002-06 Impact factor: 17.425
Authors: Zoran Stankovic; Bernd Jung; Jeremy Collins; Maximilian F Russe; James Carr; Wulf Euringer; Lena Stehlin; Zoltan Csatari; Peter C Strohm; Mathias Langer; Michael Markl Journal: Magn Reson Med Date: 2013-09-09 Impact factor: 4.668
Authors: Zoran Stankovic; Jury Fink; Jeremy D Collins; Edouard Semaan; Maximilian F Russe; James C Carr; Michael Markl; Mathias Langer; Bernd Jung Journal: MAGMA Date: 2014-08-07 Impact factor: 2.310
Authors: Zoran Stankovic; Martin Rössle; Wulf Euringer; Michael Schultheiss; Riad Salem; Alex Barker; James Carr; Mathias Langer; Michael Markl; Jeremy D Collins Journal: Eur Radiol Date: 2015-04-08 Impact factor: 5.315
Authors: Alejandro Roldán-Alzate; Christopher J Francois; Oliver Wieben; Scott B Reeder Journal: AJR Am J Roentgenol Date: 2016-05-17 Impact factor: 3.959